Delivery Order SPE2DB22D2206-SPE2DB25FGL09
Award Date 4/7/25
Potential Completion Date 4/28/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,428.06 firm fixed-price delivery order contract is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of June 20, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $13,094.84 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary...
- This is a delivery order (SPE2DB25FDX38) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TABRECTA 200 MG TABLET UU 56S. The order is a firm-fixed-price contract with a ceiling value of $13,094.84 and an ultimate completion date of November 14, 2024. This order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for TABRECTA 200 mg tablets (56-count units) valued at $7,214.03 under a firm fixed-price contract type. The award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,321.13 firm fixed-price delivery order contract is for the supply of TABRECTA 200 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on December 23, 2024. No set-aside designation was used for this open competition award. AmerisourceBergen...
- This federal contract award was issued by the Department of Defense (DoD) agency, Medical Supply Chain, to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The $6,547.42 firm fixed-price delivery order is for the supply of 4564654292 TABRECTA 200 MG TABLET UU 56S, with a completion date of June 11, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical with a potential value of $13,094.84. The order is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of March 21, 2024. This Delivery Order does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and holds an Indefinite...
- This federal contract award, valued at $13,547.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TABRECTA 200 MG TABLET UU 56S, a specialty medication, with a completion date of December 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FFD89, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, with an ultimate completion date of February 10, 2025 and a ceiling value of $28,856.12. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award....